824430-72-0

Basic information

• Product Name: INDEX NAME NOT YET ASSIGNED
• CAS NO: 824430-72-0
• Molecular Formula: C11H13Cl2N
• Molecular Weight: 230.13362
• Product Categories: METHYL
• Mol File: 824430-72-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: INDEX NAME NOT YET ASSIGNED(CAS DataBase Reference)
• NIST Chemistry Reference: INDEX NAME NOT YET ASSIGNED(824430-72-0)
• EPA Substance Registry System: INDEX NAME NOT YET ASSIGNED(824430-72-0)

Safety Data

• Hazardous Substances Data: 824430-72-0(Hazardous Substances Data)

Upstream product

• 616202-51-8 1-(8-chloro-1-methyl-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-2,2,2-trifluoroethan-1-one 
• 616202-78-9 (1S)-N-trifluoroacetyl-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine 
• 616202-89-2 (1R)-N-trifluoroacetyl-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine 
• 849663-16-7 8,9-dichloro-1-methyl-1,3,4,5-tetrahydro-benzo[d]azepin-2-one 
• 34164-22-2 2-Chloro-N-[2-(3,4-dichloro-phenyl)-ethyl]-propionamide 
• 21581-45-3 2-(3,4-dichlorophenyl)ethanamine 
• 824430-71-9 (1R,S)-8,9-dichloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine 
• 824430-73-1 (S)-N-trifluoroacetyl-8,9-dichloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine 
• 1431697-94-7 (±)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride 

Downstream Products

• 824430-76-4 (R)-8,9-dichloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine 

Relevant articles and documents

ADAMTS INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF

Compounds of formula (I) useful as inhibitors of ADAMTS-5 and/or ADAMTS-4, pharmaceutical compositions thereof, and use of them as therapeutic agents for the treatment of diseases involving degradation of cartilage or disruption of cartilage homeostasis, in particular osteoarthrosis and/or rheumatoid arthritis, are disclosed.

BENZAZEPINE DERIVATIVES USEFUL FOR THE TREATMENT OF 5HT2C RECEPTOR ASSOCIATED DISEASES

The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.